Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Mod Pathol. 2015 Sep;28(9):1265-74. doi: 10.1038/modpathol.2015.83. Epub 2015 Jul 24.
Pigment deposition is occasionally seen in hepatocellular adenomas. Several reports suggest that pigmented hepatocellular adenomas have increased risk of malignancy, but these tumors remain incompletely understood. To determine the frequency of pigment deposition, we evaluated and classified 109 well-differentiated hepatocellular neoplasms that were originally diagnosed or submitted in consultation as hepatocellular adenomas and found 27 (25%) pigmented tumors. All were negative on iron stain and in three cases electron microscopy confirmed the pigment was lipofuscin. The lipofuscin intensely stained with glypican-3 in most cases (89%). Of the 27 pigmented tumors, 11 cases (41%) were classified as hepatocellular adenomas, 7 cases (27%) were classified as atypical hepatocellular adenomas/hepatocellular neoplasms of uncertain malignant potential, and 9 cases (33%) were reclassified as well-differentiated hepatocellular carcinomas. Four (of 9) hepatocellular carcinomas arose in pigmented hepatocellular adenomas, giving a rate of malignant transformation in pigmented hepatocellular adenomas of 27%. Of the total 27 pigmented tumors, 78% were in women and 22% in men, but interestingly only men had tumors classified as hepatocellular carcinoma or hepatocellular neoplasm of uncertain malignant potential. Also of note, a total of 10 individuals (37%) had multiple hepatocellular neoplasms but in 9 of these cases the other adenomas were non-pigmented. Importantly, in cases with multiple hepatocellular neoplasms, only the pigmented hepatocellular neoplasms had atypia or malignancy. Genotype-phenotype classification of the pigmented tumors showed different subtypes: HNF1α inactivated (48%), β-catenin activated (26%), inflammatory (15%), concurrently β-catenin activated and inflammatory in 1 hepatocellular adenoma, concurrently HNF-1α inactivated and β-catenin activated in 1 hepatocellular adenoma, and unclassified in 1 hepatocellular carcinoma. In conclusion, hepatocellular adenomas with lipofuscin pigment are a heterogeneous group of adenomas, with HNF-1α inactivation being the commonest genotype. They have an increased risk of atypia and malignancy, especially in males.
色素沉着偶尔可见于肝细胞腺瘤中。有几项报告表明,色素性肝细胞腺瘤恶性转化的风险增加,但这些肿瘤仍不完全了解。为了确定色素沉着的频率,我们评估和分类了 109 例分化良好的肝细胞肿瘤,这些肿瘤最初被诊断为或提交咨询为肝细胞腺瘤,发现 27 例(25%)色素性肿瘤。所有铁染色均为阴性,在 3 例病例中,电子显微镜证实色素为脂褐素。脂褐素在大多数情况下(89%)与 Glypican-3 强烈染色。在 27 例色素性肿瘤中,11 例(41%)分类为肝细胞腺瘤,7 例(27%)分类为非典型肝细胞腺瘤/恶性潜能不确定的肝细胞肿瘤,9 例(33%)重新分类为分化良好的肝细胞癌。4 例(9 例)肝细胞癌发生在色素性肝细胞腺瘤中,色素性肝细胞腺瘤的恶性转化率为 27%。在总共 27 例色素性肿瘤中,78%为女性,22%为男性,但有趣的是,只有男性的肿瘤被分类为肝细胞癌或恶性潜能不确定的肝细胞肿瘤。此外,共有 10 人(37%)患有多个肝细胞肿瘤,但在这些病例中,其他腺瘤是非色素性的。值得注意的是,在有多个肝细胞肿瘤的病例中,只有色素性肝细胞肿瘤具有异型性或恶性。色素性肿瘤的基因型-表型分类显示了不同的亚型:HNF1α 失活(48%)、β-catenin 激活(26%)、炎症(15%),1 例肝细胞腺瘤同时存在β-catenin 激活和炎症,1 例肝细胞腺瘤同时存在 HNF-1α 失活和β-catenin 激活,1 例肝细胞癌未分类。总之,含有脂褐素色素的肝细胞腺瘤是一组具有异质性的腺瘤,HNF-1α 失活是最常见的基因型。它们具有异型性和恶性转化的风险增加,特别是在男性中。